semaglutide blood in urine Effects of on Albuminuria and Kidney Function People With Overweight or Obesity With or Without Type 2 Diabetes: Exploratory Analysis From the STEP 1, 2, and 3 Trials Ozempic and GLP-1 Drugs: Risk

Discover how semaglutide reshapes your relationship with food and why many patients report eating to live, not living to eat

Review Calibrate's research on obesity treatment with GLP-1 medication and lifestyle changes, showing significant weight loss despite medication access challenges.

Understanding the root causewhether timing, dose, food choices, or individual geneticshelps restore the hunger control you expect from GLP-1 therapy

Clinicians should maintain heightened awareness for aspiration risk in perioperative settings

Real-World Cardiovascular Outcomes of Obesity Treatment With Tirzepatide Versus Semaglutide in Non-Diabetic Adults In obese individuals without diabetes, tirzepatide was associated with a lower risk of cardiovascular events, especially incident HF, compared with semaglutide,

How do you pick the right patients